Also known as: Egrifta

FDA-approved GHRH analog (Egrifta) for HIV-associated lipodystrophy. Established clinical evidence.

📖 Read the full Tesamorelin research overview →

Evidence Tier: Tier 2 — Clinical Trials · Peptidings Verdict: Reasonable Bet